Clinical Trials
2 trialsNCT07292207 2025-12-18
ARCHE
Nagoya City University
Phase 2 Not yet recruiting
NCT06229067 2024-01-29
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting